There is much to be learnt about the costs of multiple sclerosis in Latin America

Cost-effectiveness of disease-modifying therapy for multiple sclerosis: A population-based study

(2011) K. Noyes et al.   NEUROLOGY

PND42 BRAZILIAN NATIONAL GUIDELINE FOR MULTIPLE SCLEROSIS (MS): AN EXPLORATORY STUDY ABOUT THE IMPACT OF THE PATIENT'S ADHERENCE IN THE TREATMENT COSTS

(2011) RLP Bueno et al.   VALUE IN HEALTH

PND6 VALUE OF BUDGET IMPACT ANALYSIS BASED ON EPIDEMIOLOGIC DATA: INSIGHTS FROM MULTIPLE SCLEROSIS IN SAO PAULO, BRAZIL

(2011) AL Ferreira Da Silva et al.   VALUE IN HEALTH

PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZIL

(2011) M.M.S. Takemoto et al.   VALUE IN HEALTH

Costos de la Esclerosis Múltiple en Colombia

(2011) Martin Romero et al.   VALUE IN HEALTH

Pharmacoeconomic Considerations in the Treatment of Multiple Sclerosis

(2010) Jessica Sharac et al.   DRUGS

Life issues in multiple sclerosis

(2010) Rex D. Simmons   Nature Reviews Neurology

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

A systematic review of the epidemiology of multiple sclerosis in South America

(2008) E. Cristiano et al.   EUROPEAN JOURNAL OF NEUROLOGY